Utilization of genetically altered animals in the pharmaceutical industry. - Wikidata - awgldk - TriplyDB

Utilization of genetically altered animals in the pharmaceutical industry.

Utilization of genetically altered animals in the pharmaceutical industry.

http://www.wikidata.org/entity/Q33178518

about

Tnfa signaling through tnfr2 protects skin against oxidative stress-induced inflammation Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors Strategic importance of research support through pathology.Genetic engineering of animals: ethical issues, including welfare concerns Inflammation in central nervous system injury The use of genetically modified mice in cancer risk assessment: challenges and limitations.Response of Htr3a knockout mice to antidepressant treatment and chronic stress.Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury.Commentary: Discovery Toxicology--a nascent science.A non-canonical function of telomerase RNA in the regulation of developmental myelopoiesis in zebrafish.

P2860

Q27314999-DD7A48F7-9C88-4A32-BBC3-A10614E94702 Q34048247-FD94CA18-1D21-4171-B319-9B5D233161CC Q34560269-65F4148B-C52F-4533-8339-D0EB63CBADC2 Q34802900-997C61E5-75DA-4C4F-BBA0-26FB6E26B51D Q35213716-A18977C8-4523-4150-9A06-5A7FF27EDD9C Q35688431-E9CEEC94-AA62-4054-8900-A75788D9C983 Q38792343-5945BAF3-DF59-4C0C-8897-80755594F24C Q43936965-E4EF7B10-9EDE-4E1D-8514-19475C276D8A Q50109014-850D991D-4D4B-439B-B7A8-7A92438B1F27 Q50690869-377CD865-60CA-4E29-B060-A4FBAEC814B9

P2860

Utilization of genetically altered animals in the pharmaceutical industry.

http://www.wikidata.org/entity/Q33178518

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Utilization of genetically altered animals in the pharmaceutical industry.

@ast

Utilization of genetically altered animals in the pharmaceutical industry.

@en

type

label

Utilization of genetically altered animals in the pharmaceutical industry.

@ast

Utilization of genetically altered animals in the pharmaceutical industry.

@en

prefLabel

Utilization of genetically altered animals in the pharmaceutical industry.

@ast

Utilization of genetically altered animals in the pharmaceutical industry.

@en

P1433

Q33178518-10CCE55C-399A-470C-B3C8-5EB6CC0AAED1

P1476

Q33178518-23F89977-80A0-48B0-A7D6-01B8F755B22E

P2093

Q33178518-5AA6E3F5-CADF-41B4-9668-79EFC44A7D5B

Q33178518-D0B5D988-4258-4A08-A22C-A8C82821F42C

P2860

Q33178518-0110D968-7D81-4930-A373-8DD0F9B0DE32

Q33178518-01FFFEAE-F715-4FD5-B2B6-25E7507E6653

Q33178518-028ABC62-AF85-46D8-80C7-908EA5A3AD1D

Q33178518-08668EA9-A3AD-4107-B8AD-695D2DBD67A7

Q33178518-096311C0-DBA6-4725-9EFF-72A81FAC55C0

Q33178518-0F2347C0-F715-4DA5-81F8-DD57B070BC77

Q33178518-10918E4D-770E-443B-A4CD-6BDB1005357B

Q33178518-136DF41F-3FBE-46CF-AC7C-DAACFF8C6904

Q33178518-15831EC3-4789-4AF3-BF30-B6215BFA5258

Q33178518-1BF9B541-F8CC-4092-8285-0C5EA67E9BA2

P304

Q33178518-9350150E-6B61-4BB9-A4BE-3BB04D8BE3B7

P31

Q33178518-B0354187-DE40-45C0-BA13-836FA538BD0F

P356

Q33178518-D85E9101-DE8B-4529-9862-6010D2AE3FA9

P407

Q33178518-D1367C1C-9F55-4A7C-8E7A-B56A2D0023FB

P433

Q33178518-748E1762-A26A-4A01-8709-2465D1F74E23

P478

Q33178518-EAAFAE6C-0C64-4176-8D88-9828F785D3CA

P577

Q33178518-A6209876-AB9A-441E-B597-2C20A297A068

P5875

Q33178518-397739D4-E3EB-4A03-B06B-B715473A1D37

P698

Q33178518-2471C0DD-8B94-4FF6-9789-A7AC96315CD5

P356

019262339902700121

P1433

Toxicologic Pathology

P1476

Utilization of genetically altered animals in the pharmaceutical industry.

@en

P2093

D G Rudmann

http://www.w3.org/2001/XMLSchema#string

S K Durham

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-activated site-specific recombination in mice

Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy

Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

Establishment in culture of pluripotential cells from mouse embryos

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B

Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting

Inducible gene targeting in mice

P304

111-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/019262339902700121

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12930724

http://www.w3.org/2001/XMLSchema#string

P698

10367684

http://www.w3.org/2001/XMLSchema#string